NEW: We've expanded Stock Detail, Screener, and Maps with new data

Stock Detail, Screener:
3, 5, 10-Year Performance
EV/EBITDA, EV/Sales
Dividend Growth (1, 3, 5 Years)
EPS & Sales Growth (3 Years)

Maps:
All from Screener plus:
ROA, ROE, ROIC
Quick & Current Ratios
LT Debt and Debt to Equity Ratios
Gross, Operating, and Net Margins

Screener

CLPT

ClearPoint Neuro Inc

Jun 30 • 04:00PM ET

11.94

Dollar change +0.14
Percentage change 1.19	%

Healthcare • Medical Devices • USA • NASD

Peers: AXNX NVCR NNOX NURO ARVN STXS PAVM LAKE LCTX BCLI

| Held by: VTI IWM VXF IWO IWC GSSC RSSL OMFS QQQS UWM

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-0.75	Insider Own	14.22%	Shs Outstand	27.98M	Perf Week	5.11%
Market Cap	337.49M	Forward P/E	-	EPS next Y	-0.66	Insider Trans	-1.02%	Shs Float	24.24M	Perf Month	-0.25%
Enterprise Value	328.54M	PEG	-	EPS next Q	-0.20	Inst Own	29.35%	Short Float	4.92%	Perf Quarter	-0.25%
Income	-20.79M	P/S	10.47	EPS this Y	-10.00%	Inst Trans	9.40%	Short Ratio	3.41	Perf Half Y	-23.97%
Sales	32.24M	P/B	16.71	EPS next Y	14.29%	ROA	-49.68%	Short Interest	1.19M	Perf YTD	-22.37%
Book/sh	0.71	P/C	27.24	EPS next 5Y	-	ROE	-76.21%	52W High	19.22 -37.88%	Perf Year	116.30%
Cash/sh	0.44	P/FCF	-	EPS past 3/5Y	-0.23% -10.69%	ROIC	-91.01%	52W Low	5.11 133.66%	Perf 3Y	1.96%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	24.42% 22.85%	Gross Margin	61.20%	Volatility	5.31% 5.63%	Perf 5Y	200.76%
Dividend TTM	-	EV/Sales	10.19	EPS Y/Y TTM	9.54%	Oper. Margin	-67.25%	ATR (14)	0.69	Perf 10Y	-71.27%
Dividend Ex-Date	-	Quick Ratio	2.55	Sales Y/Y TTM	23.22%	Profit Margin	-64.51%	RSI (14)	47.26	Recom	1.00
Dividend Gr. 3/5Y	- -	Current Ratio	3.51	EPS Q/Q	-33.46%	SMA20	-1.75%	Beta	0.92	Target Price	29.00
Payout	-	Debt/Eq	0.17	Sales Q/Q	11.07%	SMA50	-6.70%	Rel Volume	1.58	Prev Close	11.80
Employees	115	LT Debt/Eq	0.14	Earnings	May 13 AMC	SMA200	-11.79%	Avg Volume	349.18K	Price	11.94
IPO	May 21, 2012	Option/Short	Yes / Yes	EPS/Sales Surpr.	-38.63% 3.40%	Trades		Volume	550,213	Change	1.19%

Date	Action	Analyst	Rating Change	Price Target Change
Jul-25-24	Resumed	B. Riley Securities	Buy	$10
Oct-24-23	Initiated	Stifel	Buy	$8
Feb-16-23	Resumed	B. Riley Securities	Buy	$14
Apr-05-22	Resumed	B. Riley Securities	Buy	$15
Mar-18-21	Initiated	Lake Street	Buy	$32
Jul-17-20	Initiated	B. Riley FBR	Buy	$8

Jun-09-25 02:15PM	ClearPoint Neuro, Inc. (CLPT): A Bull Case Theory (Insider Monkey)
Jun-04-25 08:55AM	Lake Street says AMT-130 could be significantly impactful for ClearPoint (TipRanks)
May-15-25 08:06AM	5 High-Flying Medical Instrument Stocks to Buy Despite Recent Turmoil (Zacks)
May-14-25 03:16AM	ClearPoint Neuro Inc (CLPT) Q1 2025 Earnings Call Highlights: Navigating Growth Amidst Challenges (GuruFocus.com) -12.46%
May-13-25 05:35PM	ClearPoint Neuro, Inc. (CLPT) Reports Q1 Loss, Tops Revenue Estimates (Zacks)
04:40PM	Loading…
04:40PM	ClearPoint Neuro Reports First Quarter 2025 Results (ACCESSWIRE)
09:55AM	Wall Street Analysts Believe ClearPoint Neuro (CLPT) Could Rally 102.86%: Here's is How to Trade (Zacks)
May-12-25 04:05PM	ClearPoint Neuro Announces Investment of up to $110 Million by Oberland Capital with $33.5 Million Funded at Closing (ACCESSWIRE)
09:34AM	ClearPoint Neuro Inc (CLPT) Q1 2025 Earnings Report Preview: What to Look For (GuruFocus.com)
May-08-25 05:45PM	Sight Sciences, Inc. (SGHT) Reports Q1 Loss, Tops Revenue Estimates (Zacks) +7.22%
May-07-25 05:40PM	OrthoPediatrics (KIDS) Reports Q1 Loss, Tops Revenue Estimates (Zacks)
May-01-25 07:50AM	Teleflex (TFX) Tops Q1 Earnings and Revenue Estimates (Zacks)
Apr-30-25 05:10AM	Deep Sail Capital Partner Q1 2025 Investor Letter (Seeking Alpha)
Apr-29-25 12:00AM	ClearPoint Neuro: Fundamentals Continue To Strengthen (Seeking Alpha)
Apr-28-25 08:00AM	ClearPoint Neuro, Together with its Partner Clinical Laserthermia Systems, Announces FDA Submission to Expand the Labeling of ClearPoint Prism(R) to Include 1.5 T MRI (ACCESSWIRE)
08:00AM	Loading…
Apr-25-25 08:00AM	ClearPoint Neuro to Announce First Quarter 2025 Results May 13, 2025 (ACCESSWIRE)
Apr-24-25 08:00AM	ClearPoint Neuro Announces Full Market Release of ClearPoint Navigation Software Version 3.0 - Delivering the First End-to-End ClearPoint Navigation Solution to the Operating Room (ACCESSWIRE) +7.85%
Apr-10-25 05:47AM	IDEXX (IDXX) Surges 10.0%: Is This an Indication of Further Gains? (Zacks) -8.08%
Feb-26-25 04:05PM	ClearPoint Neuro Reports Fourth Quarter and Full Year 2024 Results (ACCESSWIRE) -17.51%
Feb-25-25 10:55AM	ClearPoint Neuro Inc (CLPT) Q4 2024: Everything You Need To Know Ahead Of Earnings (GuruFocus.com)
Feb-14-25 08:00AM	ClearPoint Neuro to Announce Fourth Quarter and Full Year 2024 Results February 26, 2025 (ACCESSWIRE)
Feb-12-25 04:15PM	ClearPoint Neuro Announces EU MDR Certification for the SmartFlow Cannula (ACCESSWIRE)
Jan-29-25 08:32AM	ClearPoint Neuro price target raised to $20 from $15 at B. Riley (TipRanks)
Jan-28-25 09:20AM	ClearPoint Neuro, Inc. (CLPT): A Bull Case Theory (Insider Monkey) +5.53%
Jan-27-25 04:05PM	ClearPoint Neuro Announces FDA Clearance for ClearPoint Navigation Software Version 3.0 (ACCESSWIRE)
Nov-13-24 06:15PM	ClearPoint Neuro Announces FDA De Novo Marketing Authorization of SmartFlow Cannula for Direct Delivery of Gene Therapy to the Brain (ACCESSWIRE)
Nov-07-24 04:05PM	ClearPoint Neuro Reports Third Quarter 2024 Results (ACCESSWIRE) -13.19%
Nov-06-24 07:38AM	ClearPoint Neuro Inc (CLPT) Q3 2024 Earnings Report Preview: What To Expect (GuruFocus.com)
Oct-31-24 04:05PM	ClearPoint Neuro to Participate in Multiple Global Healthcare Conferences in the Fourth Quarter of 2024 (ACCESSWIRE)
Oct-17-24 04:05PM	ClearPoint Neuro to Announce Third Quarter 2024 Results November 7, 2024 (GlobeNewswire) +11.61%
04:05PM	Loading…
Aug-26-24 04:05PM	ClearPoint Neuro Announces Early Repayment of $10 Million Note (GlobeNewswire) +8.97%
Aug-07-24 04:05PM	ClearPoint Neuro Reports Second Quarter 2024 Results (GlobeNewswire) +40.68%
Jul-17-24 04:05PM	ClearPoint Neuro to Announce Second Quarter 2024 Results August 7, 2024 (GlobeNewswire)
Jul-10-24 03:51AM	Strength Seen in ClearPoint Neuro (CLPT): Can Its 16.9% Jump Turn into More Strength? (Zacks) +9.88%
Jun-20-24 08:45AM	ClearPoint Neuro Congratulates Partner Aspen Neuroscience on Use of the ClearPoint Navigation System for All Enrolled Patients in ASPIRO Clinical Trial (GlobeNewswire) +5.52%
08:30AM	Parkinson's Disease Clinical Trial Uses Intraoperative MRI to Guide Precision Implantation of Patients' Own Autologous Replacement Neurons (PR Newswire)
Jun-03-24 11:53AM	ClearPoint's (CLPT) New Products to Boost Neurosurgical Segment (Zacks)
Jun-01-24 09:00AM	ClearPoint Neuro Announces Full Market Release of SmartFrame OR and ClearPoint PRISM 3T Laser Therapy System (GlobeNewswire)
May-29-24 09:55AM	Does ClearPoint Neuro (CLPT) Have the Potential to Rally 81.49% as Wall Street Analysts Expect? (Zacks)
May-13-24 09:55AM	Wall Street Analysts Predict a 70.65% Upside in ClearPoint Neuro (CLPT): Here's What You Should Know (Zacks)
May-08-24 03:53AM	ClearPoint Neuro Inc (CLPT) Q1 2024 Earnings Call Transcript Highlights: Robust Revenue Growth ... (GuruFocus.com)
May-07-24 08:58PM	CLPT Stock Earnings: ClearPoint Neuro Beats EPS, Beats Revenue for Q1 2024 (InvestorPlace)
04:05PM	ClearPoint Neuro Reports First Quarter 2024 Results (GlobeNewswire)
May-02-24 04:05PM	ClearPoint Neuro to Present Novel Research and Exhibit at the 27th American Society of Gene & Cell Therapy Annual Meeting in Baltimore (GlobeNewswire) +6.34%
May-01-24 04:30PM	7 Penny Stocks That Could Make You a Fortune (If You Dare) (InvestorPlace)
Apr-29-24 08:00AM	ClearPoint Neuro Announces FDA Clearance of Prism Bone Anchor Accessory (GlobeNewswire)
Apr-24-24 04:05PM	ClearPoint Neuro Announces Initiation of Limited Market Release for the SmartFrame OR Stereotactic System (GlobeNewswire)
Apr-23-24 04:05PM	ClearPoint Neuro to Announce First Quarter 2024 Results May 7, 2024 (GlobeNewswire)
Apr-16-24 04:05PM	ClearPoint Neuro Congratulates its Partner AviadoBio on First Patient Treated in its ASPIRE-FTD Clinical Trial Evaluating AVB-101 for Frontotemporal Dementia with GRN Mutations (GlobeNewswire)
Mar-27-24 08:32AM	Why ClearPoint Neuro (CLPT) Stock Might be a Great Pick (Zacks)
Mar-19-24 08:07AM	ClearPoint Neuro Congratulates its Partner PTC Therapeutics on Completion of Biologics License Application Submission to FDA for Upstaza as a Treatment for AADC Deficiency (GlobeNewswire)
Mar-16-24 03:39PM	ClearPoint Neuro, Inc. (NASDAQ:CLPT) Q4 2023 Earnings Call Transcript (Insider Monkey)
Mar-12-24 05:40PM	ClearPoint Neuro, Inc. (CLPT) Reports Q4 Loss, Tops Revenue Estimates (Zacks) +18.51%
05:39PM	ClearPoint Neuro Inc Reports Robust Revenue Growth in Q4 and Full-Year 2023 (GuruFocus.com)
04:05PM	ClearPoint Neuro Reports Fourth Quarter and Full-Year 2023 Results (GlobeNewswire)
10:36AM	ClearPoint's (CLPT) Prism System Favored by Latest Study (Zacks)
Mar-11-24 08:00AM	Journal of Neurosurgery Publication Demonstrates Distinct Advantages of ClearPoint Prism Neuro Laser Therapy System (GlobeNewswire)
Mar-01-24 04:05PM	ClearPoint Neuro to Announce Fourth Quarter and Full Year 2023 Results March 12, 2024 (GlobeNewswire)
Feb-29-24 08:00AM	ClearPoint Neuro Announces Pricing of Public Offering of 2,307,694 Shares of Common Stock (GlobeNewswire) -17.23%
Feb-28-24 04:45PM	ClearPoint Neuro Launches Proposed Public Offering of Common Stock (GlobeNewswire)
Feb-26-24 11:01AM	ClearPoint Neuro (CLPT) Gets FDA's Nod for New Software (Zacks)
Feb-21-24 04:05PM	ClearPoint Neuro Announces FDA Clearance and First-in-Human Cases Performed with the New 2.2 Software Version and the Integrated Maestro Brain Model (GlobeNewswire)
Jan-24-24 04:05PM	ClearPoint Neuro Announces Installation and First Procedure Using the ClearPoint Prism Neuro Laser Therapy System and Navigation System at Kaleida Health in Buffalo (GlobeNewswire) -7.39%
Jan-22-24 04:05PM	ClearPoint Neuro Announces First EU MDR Certification Success and Approval to Ship Product to Europe (GlobeNewswire)
Jan-17-24 10:38AM	ClearPoint Neuro (CLPT) Gets FDA's Nod for SmartFrame OR System (Zacks)
Jan-16-24 08:00AM	ClearPoint Neuro Announces FDA Clearance for SmartFrame OR Stereotactic System (GlobeNewswire) +5.30%
Jan-08-24 04:05PM	ClearPoint Neuro Reports Fourth Quarter and Full Year 2023 Preliminary Revenue Results and Guidance for Full Year 2024 Revenue (GlobeNewswire) +17.91%
Nov-10-23 02:38PM	ClearPoint Neuro, Inc. (NASDAQ:CLPT) Q3 2023 Earnings Call Transcript (Insider Monkey) -17.71%
Nov-09-23 04:05PM	ClearPoint Neuro Reports Third Quarter 2023 Results (GlobeNewswire) -7.82%
Oct-26-23 04:05PM	ClearPoint Neuro to Announce Third Quarter 2023 Results November 9, 2023 (GlobeNewswire) -6.02%
Aug-08-23 04:05PM	ClearPoint Neuro Reports Second Quarter 2023 Results (GlobeNewswire)
Jul-25-23 04:05PM	ClearPoint Neuro to Announce Second Quarter 2023 Results August 8, 2023 (GlobeNewswire)
May-24-23 09:25AM	ClearPoint Neuro and UCB Enter License Agreement for Gene Therapy Drug Delivery (GlobeNewswire)
May-18-23 04:01PM	ClearPoint Neuro to Present at the B. Riley Securities 2023 Institutional Investor Conference (GlobeNewswire)
May-11-23 04:05PM	ClearPoint Neuro Reports First Quarter 2023 Results (GlobeNewswire) -5.41%
May-10-23 04:05PM	ClearPoint Neuro to Present Investigational Research and Showcase Novel Innovations at the 26th American Society of Gene & Cell Therapy Annual Meeting in Los Angeles (GlobeNewswire)
Apr-28-23 04:42PM	ClearPoint Neuro to Announce First Quarter 2023 Results May 11, 2023 (GlobeNewswire)
Apr-20-23 04:05PM	ClearPoint Neuro to Showcase Two Novel Innovations at AANS 2023: ClearPoint Maestro® Brain Model and ClearPoint Prism Neuro Laser Therapy System (GlobeNewswire)
Apr-18-23 04:05PM	ClearPoint Neuro Announces Agreement with NE Scientific to Integrate Gene Therapy Infusion Coverage Tool into ClearPoint Maestro® Brain Model (GlobeNewswire)
12:33PM	Market Participants Recognise ClearPoint Neuro, Inc.'s (NASDAQ:CLPT) Revenues Pushing Shares 37% Higher (Simply Wall St.)
Apr-13-23 04:05PM	ClearPoint Neuro Announces ANVISA Approval of Neuro Navigation Portfolio in Brazil (GlobeNewswire) +11.01%
Apr-11-23 04:05PM	ClearPoint Neuro Extends Software License and Research Agreement with Philips to Include Fully Automatic Subnuclei Segmentation for DBS (GlobeNewswire)
Mar-28-23 04:05PM	ClearPoint Neuro Announces Exclusive Multi-Year Licensing Agreement with UCSF for Innovative Intra-Cerebral Cellular Delivery Platform (GlobeNewswire) +6.29%
Mar-01-23 04:05PM	ClearPoint Neuro Reports Fourth Quarter and Full-Year 2022 Results (GlobeNewswire) +7.19% -9.79%
Feb-15-23 04:05PM	ClearPoint Neuro to Announce Fourth Quarter and Full Year 2022 Revenue Results March 1, 2023 (GlobeNewswire)
Jan-11-23 08:00AM	ClearPoint Neuro Reports Fourth Quarter and Full Year 2022 Preliminary Revenue Results and Guidance for Full Year 2023 Revenue (GlobeNewswire)
Dec-12-22 09:15AM	ClearPoint Neuro Announces First Patient Enrolled in Glioblastoma Trial Using ClearPoint Prism Neuro Laser Therapy System at Skåne University Hospital in Sweden (GlobeNewswire)
Nov-09-22 09:25AM	ClearPoint Neuro to Present at Upcoming Investor Conferences (GlobeNewswire) -5.37%
Nov-08-22 04:05PM	ClearPoint Neuro Reports Third Quarter 2022 Results (GlobeNewswire)
Oct-26-22 04:05PM	ClearPoint Neuro to Announce Third Quarter 2022 Results November 8, 2022 (GlobeNewswire)
Sep-23-22 02:45AM	ClearPoint Neuro Announces FDA Clearance for ClearPoint Prism Neuro Laser Therapy System (GlobeNewswire) +5.04%
Sep-20-22 04:05PM	ClearPoint Neuro Announces Appointment of Mazin Sabra as Chief Operating Officer (GlobeNewswire) -5.27%
Sep-19-22 04:13PM	ClearPoint Neuro Announces FDA Clearance for Software Version 2.1 (GlobeNewswire)
Aug-09-22 04:15PM	ClearPoint Neuro Reports Second Quarter 2022 Results (GlobeNewswire) +13.57%
04:05PM	ClearPoint Neuro Announces FDA Clearance for ClearPoint Maestro Brain Model (GlobeNewswire)
Aug-08-22 04:05PM	ClearPoint Neuro, Inc. Announces Appointment of Mary McNamara-Cullinane as Vice President of Regulatory Affairs (GlobeNewswire)
Jul-26-22 04:05PM	ClearPoint Neuro to Announce Second Quarter 2022 Results August 9, 2022 (GlobeNewswire) +5.47%
Jul-21-22 04:20PM	ClearPoint Neuro Congratulates Partner PTC Therapeutics on Being Granted Marketing Authorization by the European Commission for Upstaza - First Disease-Modifying Treatment for AADC Deficiency (GlobeNewswire) -7.81%
Jun-29-22 04:05PM	ClearPoint Neuro Congratulates Neurona Therapeutics on Dosing of Initial Subject in First Clinical Trial of Regenerative Human Cell Therapy in Adults with Drug-Resistant Focal Epilepsy (GlobeNewswire)
Jun-02-22 04:05PM	ClearPoint Neuro Announces Receipt of MDSAP Certification (GlobeNewswire) +5.85%

Clearpoint Neuro, Inc. engages in the development and commercialization of platforms for performing minimally invasive surgical procedures in the brain and heart. The firm conducts its procedures under direct, intra-procedural magnetic resonance imaging guidance. Its product platform consists of the ClearPoint system and ClearTrace system. The company was founded by Paul A. Bottomley on March 12, 1998 and is headquartered in Solana Beach, CA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Richards Timothy T.	Director	Jun 10 '25	Sale	13.28	10,000	132,800	77,381	Jun 12 07:26 PM
BURNETT JOSEPH	CEO and President	Jun 09 '25	Sale	13.29	21,247	282,373	243,522	Jun 11 09:50 PM
TIMOTHY RICHARDS	Director	Jun 10 '25	Proposed Sale	13.28	10,000	132,843		Jun 10 04:35 PM
JOSEPH M BURNETT TRUST	Officer	Jun 09 '25	Proposed Sale	13.29	21,247	282,358		Jun 09 04:08 PM
FALLON LYNNETTE C	Director	Jun 03 '25	Sale	12.57	10,200	128,226	40,901	Jun 05 04:17 PM
LYNNETTE FALLON	Director	Jun 03 '25	Proposed Sale	12.57	10,200	128,231		Jun 03 04:13 PM

CLPT

ClearPoint Neuro Inc

Upgrade your FINVIZ experience